News

A total of 711 patients have been randomized in 123 clinical centers in the US, Europe and South America for Ardis 1. This study is the first of

The grant will support a total of nearly $200 million investment by Agfa HealthCare in its Ontario operations, creating 100 new positions and re-investing in 276 existing jobs.

According to the company, cartridges for E3+, EC4+ and 6+ aid the clinician in assessing a patient’s metabolic state within a few minutes. The glucose cartridge quickly delivers

The CE Mark enables Access Scientific to sell the MicroAccess Wand broadly around the globe. The device has already received the FDA clearance. According to the company, the

Mr Peacock is president and CEO of Alba Therapeutics, and has also been a venture partner with SV Life Sciences since May 2006. Mr Peacock currently serves as

GlaxoSmithKline (GSK) said that it is the first time the European Commission has approved a non-prescription product for weight loss. The centrally approved marketing authorization means GSK can

Mr Keltjens will succeed Eamonn Hobbs, a co-founder of AngioDynamics, who has led the company for the past 21 years and will become vice chairman of the board

PharmaSurgics patented drug candidate PXL01, has demonstrated an excellent effect and safety profile in preclinical studies and the first clinical trial on patients are planned to start in

The FlexStent femoropopliteal self expanding stent system is indicated for the treatment of peripheral vascular lesions involving the superficial femoral and popliteal arteries. The fully connected flexible FlexStent